The Plasma Protein Therapeutics Association (PPTA) invites you to join Beyond Labels: Ensuring Access to IG Therapy for Secondary Immunodeficiency, a virtual educational webinar on Friday, August 7, 2026, from 9:00–10:30 a.m. ET.
Secondary immunodeficiency (SID), with a focus on hypogammaglobulinemia, which is an acquired antibody deficiency characterized by low immunoglobulin levels that can leave patients vulnerable to serious infections and other complications. As evidence continues to evolve, ongoing dialogue among clinicians, researchers, regulators, patients, and other stakeholders is essential to supporting patient-centered care and informed decision-making.
This webinar will bring together leading experts to explore the current landscape from multiple perspectives, including:
- A patient perspective on living with secondary immunodeficiency
- Physician-scientist insights on the evolving clinical evidence
- Regulatory considerations, including the European Medicines Agency's perspective
- Broader discussions on responsible, patient-centered care pathways
Featured speakers include:
- Dr. James Knowles, Vice President, Global Regulatory Policy & Scientific Affairs, PPTA
- Caroline Voltz-Girolt, Scientific Lead, Oncology and Hematology Office, European Medicines Agency (EMA)
- Charlene Grabowski, Patient and Board Member, Immune Deficiency Foundation (IDF)
- Dr. Stephan Grupp, Section Chief, Cellular Therapy and Transplant, Children's Hospital of Philadelphia (CHOP)
The program is intended to foster education and dialogue among healthcare professionals, regulators, researchers, patient advocates, and other stakeholders interested in advancing care for patients with secondary immunodeficiency.
Register today to reserve your place.